Cargando…

The co-management of tuberculosis-diabetes co-morbidities in Indonesia under the National Tuberculosis Control Program: results from a cross-sectional study from 2017 to 2019

BACKGROUND: Indonesia suffers from a high burden of tuberculosis (TB) and diabetes (DM). The government initiated national TB-DM co-management activities under the National TB Control Program in 2017. This study investigates the detection and treatment outcomes of TB-DM in Jakarta after implementing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Weixi, Trimawartinah, Rahman, Fauziah Mauly, Wibowo, Adik, Sanjaya, Adhi, Silitonga, Permata Imani Ima, Tang, Shenglan, Long, Qian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990273/ https://www.ncbi.nlm.nih.gov/pubmed/35395745 http://dx.doi.org/10.1186/s12889-022-13017-y

Ejemplares similares

Socioeconomic, geographic and health system factors associated with rising C-section rate in Indonesia: a cross-sectional study using the Indonesian demographic and health surveys from 1998 to 2017
por: Wyatt, Sage, et al.
Publicado: (2021)

Application of serial tests for Mycobacterium tuberculosis detection to active lung tuberculosis cases in Indonesia
por: Sari, Nastiti Intan Permata, et al.
Publicado: (2019)

Antimicrobial sensitivity of Avibacterium paragallinarum isolates from layers in the special region of Yogyakarta, Indonesia
por: Fauziah, Ima, et al.
Publicado: (2021)

Morbidity Trends and Risk of Tuberculosis: Mexico 2007–2017
por: Bello-López, Juan Manuel, et al.
Publicado: (2019)

Survival of Cancer Patients with Co-Morbid Tuberculosis in Thailand
por: Siewchaisakul, Pallop, et al.
Publicado: (2021)

Plasma Eicosanoid Levels in Tuberculosis and Tuberculosis-Diabetes Co-morbidity Are Associated With Lung Pathology and Bacterial Burden
por: Pavan Kumar, Nathella, et al.
Publicado: (2019)

Effect of anti-tuberculosis treatment on the systemic levels of tissue inhibitors of metalloproteinases in tuberculosis – Diabetes co-morbidity
por: Kumar, Nathella Pavan, et al.
Publicado: (2021)

Disseminated tuberculosis confounding a co-morbid primary CNS lymphoma
por: Tai, Don Bambino Geno, et al.
Publicado: (2020)

Decreased survival among lung cancer patients with co-morbid tuberculosis and diabetes
por: Shieh, Shwn-Huey, et al.
Publicado: (2012)

Bangladesh national guidelines on the management of tuberculosis and diabetes mellitus co-morbidity (summary)
por: Hossain, Mohammad Delwar, et al.
Publicado: (2016)

Treatment outcomes and risk factors of extra-pulmonary tuberculosis in patients with co-morbidities
por: Khan, Amer Hayat, et al.
Publicado: (2019)

Patterns and predictors of co-morbidities in Tuberculosis: A cross-sectional study in the Philippines
por: White, Laura V., et al.
Publicado: (2020)

Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy
por: Kumar, Nathella Pavan, et al.
Publicado: (2019)

Mathematical modeling and optimal control of SARS-CoV-2 and tuberculosis co-infection: a case study of Indonesia
por: Rwezaura, H., et al.
Publicado: (2022)

The role of diabetes co-morbidity for tuberculosis treatment outcomes: a prospective cohort study from Mwanza, Tanzania
por: Faurholt-Jepsen, Daniel, et al.
Publicado: (2012)

Tuberculosis in Canada: 2017
por: LaFreniere, M, et al.
Publicado: (2019)

A New Financing Model for Tuberculosis (TB) Care in China: Challenges of Policy Development and Lessons Learned from the Implementation
por: Long, Qian, et al.
Publicado: (2020)

Transforming tuberculosis (TB) service delivery model in China: issues and challenges for health workforce
por: Wang, Ziyue, et al.
Publicado: (2019)

Moving from fear to realization: Family engagement in tuberculosis prevention in children living in tuberculosis Sundanese households in Indonesia
por: Rakhmawati, Windy, et al.
Publicado: (2019)

Submuscular gluteal abcess: An unusual presentation of rare sacral tuberculosis
por: Djaja, Yoshi Pratama, et al.
Publicado: (2018)

Policy changes and the screening, diagnosis and treatment of drug-resistant tuberculosis patients from 2015 to 2018 in Zhejiang Province, China: a retrospective cohort study
por: Jiang, Weixi, et al.
Publicado: (2021)

Heightened circulating levels of antimicrobial peptides in tuberculosis—Diabetes co-morbidity and reversal upon treatment
por: Kumar, Nathella Pavan, et al.
Publicado: (2017)

Mean platelet volume (MPV): new diagnostic indices for co-morbidity of tuberculosis and diabetes mellitus
por: Xu, Feifan, et al.
Publicado: (2021)

Spatio-Temporal Dynamics of Tuberculosis Clusters in Indonesia
por: Rengganis Wardani, Dyah Wulan Sumekar, et al.
Publicado: (2020)

Tuberculosis control within Indonesia’s hospital accreditation
por: Oktamianti, Puput, et al.
Publicado: (2021)

Tuberculosis — United States, 2017
por: Stewart, Rebekah J., et al.
Publicado: (2018)

Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia
por: Lisdawati, Vivi, et al.
Publicado: (2015)

CD4 and Its Relevance to Advanced Glycation End Products in Tuberculosis Patients with Co-morbidity Diabetes
por: Widjaja, Sry Suryani, et al.
Publicado: (2018)

Abstract: Paper presentation: Socio-demographic profile of patients with Pulmonary Tuberculosis associated with psychiatric co-morbidities.
por: Chinar, Chinar, et al.
Publicado: (2022)

Tuberculosis and HIV Co-Infection
por: Pawlowski, Andrzej, et al.
Publicado: (2012)

Co-Infection with HIV and Tuberculosis
Publicado: (2007)

Predominant Determinants of Delayed Tuberculosis Sputum Conversion in Indonesia
por: Wardani, Dyah Wulan Sumekar Rengganis, et al.
Publicado: (2019)

The socioeconomic impact of multidrug resistant tuberculosis on patients: results from Ethiopia, Indonesia and Kazakhstan
por: van den Hof, Susan, et al.
Publicado: (2016)

Elevated levels of matrix metalloproteinases reflect severity and extent of disease in tuberculosis-diabetes co-morbidity and are predominantly reversed following standard anti-tuberculosis or metformin treatment
por: Kumar, Nathella P., et al.
Publicado: (2018)

Evaluation of the Burden of Unsuspected Pulmonary Tuberculosis and Co-Morbidity with Non-Communicable Diseases in Sputum Producing Adult Inpatients
por: Bates, Matthew, et al.
Publicado: (2012)

Smoking, alcohol use disorder and tuberculosis treatment outcomes: A dual co-morbidity burden that cannot be ignored
por: Thomas, Beena Elizabeth, et al.
Publicado: (2019)

Delayed diagnosis of tuberculosis in patients with diabetes mellitus co-morbidity and its associated factors in Zhejiang Province, China
por: Xiao, Wenhui, et al.
Publicado: (2021)

Non-communicable disease co-morbidity and associated factors in tuberculosis patients: A cross-sectional study in Gabon
por: Adegbite, BR, et al.
Publicado: (2022)

Tuberculosis and diabetes mellitus: Relating immune impact of co-morbidity with challenges in disease management in high burden countries
por: Abbas, Uzair, et al.
Publicado: (2022)

A Bibliometric Analysis on Tuberculosis Research of Korea from 1979 to 2017
por: Lee, Hyun Woo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tahvnbgodrb86sqkdg8s12fmvs